Co-founder, CEO and board Chairman of The Institute for Life Changing Medicines, dedicated to saving one million people suffering from life-threatening and devastating diseases around the world with no barriers to access.
Alex is also the Co-Founder and Chief Investment Officer of Braidwell, an investment firm focused on biotechnology, pharmaceuticals, medical devices and diagnostics. In this capacity, Alex oversees Braidwell’s mission to allocate capital to assets and organizations that push the boundaries of medicine, science and technology to improve human life.
Prior to co-founding Braidwell, Alex was a Partner, Managing Director and the Co-Portfolio Manager at Deerfield, from 2005 until 2021. Beyond his day-to-day portfolio management responsibilities, Alex helped conceptualize and implement the Cure, Deerfield’s healthcare innovation campus at 345 Park Avenue South. Prior to Deerfield, he was a member of Merrill Lynch’s Global Equity Linked Products Group, as well as its Capital Markets team. During the COVID-19 global health crisis, Alex was appointed by Governor Ned Lamont to the Reopen Connecticut Advisory Group to provide counsel on the reemergence of the state’s economy, community and education systems.
Alex serves on the Boards of the Biotechnology Innovation Organization, Museum of Science and Discovery Labs, the latter of which he co-founded. He is a member of the Massachusetts Institute of Technology’s corporate development committee, focusing on student life initiatives. He previously served on the Board of The Children’s Health Fund as Vice Chairman, New York Academy of Medicine, and Recovery Centers of America, which he also co-founded. He holds a B.S. from the Massachusetts Institute of Technology and a M.S. from Johns Hopkins University.